| abstract |
The present invention relates to methods and kits for treating cancer in a subject. The method includes administering to the subject a combination of a therapeutically effective amount of a VEGF-C antagonist and an anti-tumor composition. The kit includes a VEGF-C antagonist for administration to a subject in combination with an anti-tumor composition. The present invention relates to a method for increasing survival, increasing progression free survival, increasing response duration, or treating a human subject (s) diagnosed as susceptible to cancer or cancer. Or further relates to a method for treating a human subject (s) having metastatic colorectal cancer, prostate cancer, pancreatic cancer or glioblastoma. The method includes administering an effective amount of a VEGF-C antagonist and an anti-tumor composition in combination to a plurality of subjects in a subject or group. [Selection] Figure 7 |